CRISPR Therapeutics AG
NASDAQ: CRSP
$49.79
-$0.94 (-1.9%)
Closing Price on November 13, 2024
CRSP Articles
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including Anthem, BioMarin, CRISPR, GE and more.
Published:
Thursday's top analyst upgrades and downgrades included Allstate, Bed Bath & Beyond, Simon Property, Spirit Airlines, Twitter and Under Armour.
Published:
Thursday's top analyst upgrades and downgrades included Best Buy, Booking, ConocoPhillips, CRISPR Therapeutics, Fisker, Halliburton, Lordstown Motors, RH, Tesla, Walt Disney and Zscaler.
Published:
Monday's top analyst upgrades and downgrades included Accenture, Boeing, CRISPR Therapeutics, DraftKings, Illumina, Lyft, McDonald's, Southwest Airlines and Teladoc Health.
Published:
Friday's top analyst upgrades and downgrades included Citrix Systems, CRISPR Therapeutics, Dunkin' Brands, Fastly, Intel, Mattel, PulteGroup, Sirius XM, Southwest Airlines Tesla and Under Armour.
Published:
Monday's top analyst upgrades and downgrades included American Express, AT&T, CRISPR Therapeutics, DocuSign, ONEOK, Regeneron Pharmaceuticals, Shopify and Tesla.
Published:
Tuesday's top analyst upgrades and downgrades included ADM, Beyond Meat, Bristol-Myers, Carvana, CRISPR, FirstEnergy, Peloton, Shopify, Tesla, Uber and Visa.
Published:
Monday's top analyst upgrades, downgrades and initiations included Aimmune Therapeutics, Amgen, Biogen, Chevron, CRISPR, Exxon Mobil, Nike, Snap, Uber, Ulta Beauty and Verizon.
Published:
Tuesday's top analyst upgrades, downgrades and initiations included Albermarle, Amgen, Applied Materials, Biogen, CRISPR Therapeutics, CrowdStrike, CSX, Kroger, Slack, Teva Pharmaceutical and Xerox.
Published:
Last Updated: